A new report from AARP Public Policy Institute found that the top 25 drugs prescribed under Medicare Part D have nearly ...
Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate prices concessions, Bloomberg reported. The company told USA TODAY that it would ...
Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs.
AARP’s new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...
Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included ...
More than 70,000 seniors in Washington state will save hundreds or thousands of dollars each year thanks to the new annual cap on out-of-pocket prescription drug costs for folks on Medicare Part D, ...
Top Medicare Part D drugs without price negotiations have seen a 98% increase in list prices since their launch. Read more ...
More than two years after the passage of the Inflation Reduction Act (“IRA”) and the Centers for Medicare and Medicaid Services’ (“CMS’”) ...
Concurrently, a preprint from the industry-backed Vital Transformation found a 50% drop in company investments into ...
The Fiscal Responsibility Act of 2023, which suspended the debt limit until last week, also established binding discretionary ...
President Joe Biden is set to sign a bill that will raise Social Security benefits for some pensioners, while the annual COLA will apply to all beneficiaries. These changes aim to help retirees keep ...